“The significant role of point-of-care coagulation studies: shorter cardiac surgery, better renal function and tranexamic acid cannot alone reduce early platelet transfusions”, Adv Health Res, vol. 1, no. 1, Jun. 2024, doi: 10.4081/ahr.2024.5.